当前位置:考试网  > 试卷库  > 学历类  > 自考  > 自考专业(行政管理)  > 市政学  > 试述市政体制的作用。
试题预览

试述市政体制的作用。

查看答案
收藏
纠错
正确答案:

市政体制是特定政治、经济和文化发展阶段的产物,对于维护国家政权稳定、推动城市管理工作的有效运转、促进城市社会经济有序发展具有极其重要的作用。

(1)市政体制有利于巩固和维护国家政权

城市政权是现代国家政权的重要基础,市政体制的良好运转,能够使城市政权更好地发挥治理作用,有利于国家政权的巩固和维护。

(2)市政体制是组织和开展市政管理活动的依据

市政管理活动适应了城市政权行便统治和管理职能的需要,因此城市政权的统治和管理职能决定了市政体制的性质,有什么样的城市政权统治和管理职能,也就有什么样的市政体制。

(3)市政体制的变革对城市发展具有积极的推动作用

市政体制适应时代发展的需要而进行的改革和自我完善,不仅能够缓解统治阶级内部的矛盾,加强统治阶级内部的团结,而且能够有效地推进和强化市政管理,缓和社会矛盾。

(4)市政体制的变革推进城市经济体制和社会生产力的发展

经济基础决定上层建筑,上层建筑反作用于经济基础。市政体制属于政治上层建筑,因此它必须与相应的社会生产力发展水平和经济体制相适应,否则将对其产生阻碍作用。

答案解析:

暂无解析

你可能感兴趣的试题

市政协常委会主席会议的组成主要包括()

市政体制的主要内容有哪些

下列属于市政特征的有()。

下列属于我国城市公益性组织的主要有()。

被视作中国市制的开端娃()。

热门试题 更多>
试题分类: 计算机二级
练习次数:3次
1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels.But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib,a drug designed to raise heart-protective high-density lipoproteins (HDLs).In a trial of 15000 patients,a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease."There have been no red flags to my knowledge," says John Chapman,a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib."This cancellation came as a complete shock." 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs,which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.Specifically,torcetrapib blocks a protein called cholesterol ester transfer protein (CETP),which normally transfers the cholesterol from high-density lipoproteins to low density,plaque-promoting ones.Statins,in contrast,mainly work by lowering the 'bad' low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired,something that will not become clear until the clinical details are released by Pfizer.One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients.It was thought that this mild problem would be offset by the heart benefits of the drug.But it is possible that it actually proved fatal in some patients who already suffered high blood pressure.If blood pressure is the explanation,it would actually be good news for drug developers because it suggests that the problems are specific to this compound.Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed,says Moti Kashyap,who directs atherosclerosis research at the VA Medical Center in Long Beach,California.When HDLs excrete cholesterol in the liver,they actually rely on LDLs for part of this process.So inhibiting CETP,which prevents the transfer of cholesterol from HDL to LDL,might actually cause an abnormal and irreversible accumulation of cholesterol in the body."You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients.But HDLs are complex and not entirely understood.One approved drug,called niacin,is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling.Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone.Scientists are also working on several other means to bump up high-density lipoproteins by,for example,introducing synthetic HDLs."The only thing we know is dead in the water is torcetrapib,not the whole idea of raising HDL," says Michael Miller,director of preventive cardiology at the University of Maryland Medical Center,Baltimore. Questions 7-13 Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)..Write the correct letter A,B,C or D in boxes 8-13 on your answer sheet.NB You may use any letter more than once. 7.It has been administered to over 10,000 subjects in a clinical trial. 8.It could help rid human body of cholesterol. 9.Researchers are yet to find more about it. 10.It was used to reduce the level of cholesterol. 11.According to Kashyap,it might lead to unwanted result if it's blocked. 12.It produced contradictory results in different trials. 13.It could inhibit LDLs.List of choices A.TorcetrapicB.HDLSC.StatinD.CETP
试题分类: 阅读
练习次数:3次
试题分类: 初级(口语)
练习次数:0次
扫一扫,手机做题